Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2022 Update

$ARK Innovation ETF(ARKK.US)$ $ARK Autonomous Technology & Robotics ETF(ARKQ.US)$ ARK Invest’s 13F portfolio value decreased from $23.96B to $16.91B this quarter.

Stake Disposals:
$DocuSign(DOCU.US)$ , $Iridium Communications(IRDM.US)$ , $Palantir(PLTR.US)$ , and $Twitter (Delisted)(TWTR.US)$ : These stakes were sold down last quarter and disposed this quarter.

Stake Increases:
$Zoom Video Communications(ZM.US)$
$Roku Inc(ROKU.US)$
$Block(SQ.US)$
$Exact Sciences(EXAS.US)$
$Coinbase(COIN.US)$
$Teladoc Health(TDOC.US)$
$UiPath(PATH.US)$
$Twilio(TWLO.US)$
$CRISPR Therapeutics(CRSP.US)$
$Shopify(SHOP.US)$
$Intellia Therapeutics(NTLA.US)$
$Unity Software(U.US)$
$DraftKings(DKNG.US)$
$Robinhood(HOOD.US)$
$Beam Therapeutics(BEAM.US)$
$Signify Health(SGFY.US)$
$Fate Therapeutics(FATE.US)$
Note: they have significant ownership stakes in the following businesses: 2U Inc., CareDx, Ginkgo Bioworks, Invitae, Materialise NV, Pacific Biosciences, PagerDuty, Stratasys, TuSimple, Twist Biosciences, and Veracyte.